Quality Improvement and Practice Based Research in Neurology Using the EMR
Trial
Phase 4
Enrolling by invitation
Aug. 23, 2025
Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease
Trial
N/A
Completed
Aug. 23, 2025
mHealth Technology in People With Parkinson's Disease
Trial
N/A
Completed
Aug. 23, 2025
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Trial
Phase 4
Recruiting
Aug. 23, 2025
High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners
Trial
N/A
Completed
Aug. 21, 2025
SCH: Context-aware Freezing of Gait Mitigation in Real-world Setting
Trial
N/A
Completed
Aug. 21, 2025
Dynamic Motor Cortical Responses to Subdural Electrical Stimulation.
Trial
N/A
Withdrawn
Aug. 21, 2025
EEG Measurements to Capture DBS-induced Electric Potentials
Trial
N/A
Recruiting
Aug. 20, 2025
Effect of a Vibrating Therapy Ball on Tremor and Daily Activities in Patients With Different Tremor Syndroms
Trial
N/A
Recruiting
Aug. 20, 2025
Study of AMDX-2011P as a Retinal Tracer in Subjects With Neurodegenerative Diseases Associated With Amyloidogenic Proteinopathy
Trial
Phase 1
Completed
Aug. 19, 2025
Design And Analysis of The Effectiveness of CVRE VS Non-Immersive VR in the Rehabilitation of Parkinson
Trial
N/A
Active, not recruiting
Aug. 18, 2025
PS128 May Improve Off Duration on Parkinson's Disease
Trial
N/A
Completed
Aug. 16, 2025
Opioidergic and Noradrenergic Systems in Central Parkisonian Pain
Trial
N/A
Not yet recruiting
Aug. 16, 2025
Speech Accessibility Project
Trial
N/A
Completed
Aug. 16, 2025
Top Set and Parkinson's Disease
Trial
N/A
Completed
Aug. 14, 2025
Ambroxol as a Disease-modifying Treatment in GBA-PD
Trial
Phase 2
Completed
Aug. 13, 2025
Use of a Non-Invasive Brainstem Neuromodulation Device to Improve Neurovascular Status in Parkinson's Disease
Trial
N/A
Terminated
Aug. 13, 2025
Home-based Gait and Balance Training in Patients With Movement Disorders
Trial
N/A
Recruiting
Aug. 12, 2025
Role of Pentoxifylline and Celecoxib in Parkinsonism
Trial
Phase 2
Completed
Aug. 11, 2025